These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7105886)

  • 1. Hyperprolactinemia as the first symptom of craniopharyngioma.
    Maira G; Di Rocco C; Anile C; Roselli R
    Childs Brain; 1982; 9(3-4):205-10. PubMed ID: 7105886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary dysfunction in patients with craniopharyngioma.
    Paja M; Lucas T; García-Uría J; Salamé F; Barceló B; Estrada J
    Clin Endocrinol (Oxf); 1995 May; 42(5):467-73. PubMed ID: 7621564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of craniopharyngioma with hyperprolactinemia in postoperative course (author's transl)].
    Miwa T; Yamamoto Y; Azuma S
    No Shinkei Geka; 1981 Apr; 9(5):559-66. PubMed ID: 7242837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anterior pituitary function in adult patients with craniopharyngiomas.
    Barreca T; Perria C; Francaviglia N; Rolandi E
    Acta Neurochir (Wien); 1984; 71(3-4):263-72. PubMed ID: 6430039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of craniopharyngiomas: endocrinological results.
    Honegger J; Buchfelder M; Fahlbusch R
    J Neurosurg; 1999 Feb; 90(2):251-7. PubMed ID: 9950495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
    Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
    J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperprolactinemia in craniopharyngiomas].
    Aksenova MA; Korshunov AG
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):26-9. PubMed ID: 2750397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
    Kinoshita Y; Hama S; Tominaga A; Arita K; Sugiyama K; Sakoguchi T; Usui S; Kurisu K
    J Clin Neurosci; 2011 Dec; 18(12):1651-5. PubMed ID: 22015098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas.
    Dusick JR; Fatemi N; Mattozo C; McArthur D; Cohan P; Wang C; Swerdloff RS; Kelly DF
    Surg Neurol; 2008 Nov; 70(5):482-90; discussion 490-1. PubMed ID: 18482750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum somatomedin activity in children after surgery for craniopharyngioma (authors transl)].
    Martinez MJ; Chaussain JL; Schimpff RM; Donnadieu M; Roger M; Job JC
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():881-6. PubMed ID: 7332440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniopharyngioma: endocrine sequelae of treatment.
    Sklar CA
    Pediatr Neurosurg; 1994; 21 Suppl 1():120-3. PubMed ID: 7841071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption.
    Samuels MH; Henry P; Kleinschmidt-Demasters B; Lillehei K; Ridgway EC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1289-93. PubMed ID: 1955511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
    Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
    J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amenorrhea-galactorrhea syndrome with craniopharyngioma.
    Nakasu Y; Nakasu S; Handa J; Takeuchi J
    Surg Neurol; 1980 Feb; 13(2):154-6. PubMed ID: 6101923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth in children with craniopharyngioma following surgery.
    Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craniopharyngioma: endocrine abnormalities at presentation.
    Sklar CA
    Pediatr Neurosurg; 1994; 21 Suppl 1():18-20. PubMed ID: 7841073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from diabetes insipidus and preservation of thyroid function after craniopharyngioma removal and pituitary stalk sectioning.
    Ogawa Y; Niizuma K; Tominaga T
    Clin Neurol Neurosurg; 2017 Nov; 162():36-40. PubMed ID: 28917091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience.
    Lopez-Serna R; Gómez-Amador JL; Barges-Coll J; Nathal-Vera E; Revuelta-Gutiérrez R; Alonso-Vanegas M; Ramos-Peek M; Portocarrero-Ortiz L
    Arch Med Res; 2012 Jul; 43(5):347-55. PubMed ID: 22824214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.